ACTIVE

DOKTERS BUYSE-KENIS

Financial year 2025 · Closed on 30/09/2025

Net result37,2 k €-29,5 %over 1 year
Gross margin67,1 k €-29,1 %over 1 year
Equity186,9 k €+23,5 %over 1 year

Identity

Source · BCE/KBO

DOKTERS BUYSE-KENIS is a Private limited company incorporated in 1994. Its main activity is: Other human health activities. Its registered office is in Menen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0452.360.290
Incorporation
21/03/1994
Legal form
Private limited company
Registered office
Spoorwegstraat 114
8930 Menen · FlandreSee on map
Contributed capital
18 592,01 €
Latest accounts
30/09/2025
Joint committees (1)
  • 330
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 14 financial years

20252024202320222021
Income statement
Gross margin67,1 k €94,6 k €41,4 k €79,8 k €139 k €
EBITDA66,1 k €93,7 k €41 k €65,4 k €97,4 k €
Operating result53,7 k €76,2 k €26,5 k €31 k €63,1 k €
Net result37,2 k €52,8 k €16,3 k €19,8 k €45,1 k €
Balance sheet
Equity186,9 k €151,4 k €100,3 k €103,7 k €84 k €
Total assets210,1 k €190,5 k €139,7 k €157 k €160,7 k €
Cash71,9 k €94,2 k €27,6 k €55,1 k €64,3 k €
Debts23,3 k €39,1 k €38,4 k €48,9 k €75,3 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2025

2 active · 4 ended

Active mandates

Els Kenis

Director · since 25 mars 1994

Active
Luk Buyse

Director · since 25 mars 1994

Active

Ended mandates

Els Kenis

Director

Ended
Els Kenis

Manager

Ended
Luk Buyse

Director

Ended
Luk Buyse

Manager

Ended

Other companies at this address

Spoorwegstraat 114 8930 Menen
CompanyCBE no.
0767.693.830

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/10/202401/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/04/202616/04/202530/04/202427/04/202328/04/202214/04/2021
General meeting31/03/202624/03/202530/03/202431/03/202331/03/202226/03/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/09/202531/03/202629/04/2026DutchPDF
Micro model30/09/202424/03/202516/04/2025DutchPDF
Micro model30/09/202330/03/202430/04/2024DutchPDF
Micro model30/09/202231/03/202327/04/2023DutchPDF
Micro model30/09/202131/03/202228/04/2022DutchPDF
Micro model30/09/202026/03/202114/04/2021DutchPDF
Micro model30/09/201928/02/202007/04/2020DutchPDF
Micro model30/09/201805/01/201912/04/2019DutchPDF
Micro model30/09/201719/02/201823/04/2018DutchPDF
Abridged model30/09/201604/02/201720/03/2017DutchPDF
Abridged model30/09/201529/02/201630/03/2016DutchPDF
Abridged model30/09/201427/01/201527/03/2015DutchPDF
Abridged model30/09/201324/02/201420/03/2014DutchPDF
Abridged model30/09/201205/01/201322/04/2013DutchPDF
Abridged model30/09/201107/01/201229/02/2012DutchPDF
Abridged model30/09/201003/01/201102/03/2011DutchPDF
Abridged model30/09/200902/01/201002/03/2010DutchPDF
Abridged model30/09/200803/01/200918/03/2009DutchPDF
Abridged model30/09/200705/01/200825/02/2008DutchPDF
Abridged model30/09/200606/01/200714/03/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2025

2 active · 4 ended

Active mandates

Els Kenis

Director · since 25 mars 1994

Active
Luk Buyse

Director · since 25 mars 1994

Active

Ended mandates

Els Kenis

Director

Ended
Els Kenis

Manager

Ended
Luk Buyse

Director

Ended
Luk Buyse

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates13/04/2023
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202537,2 k €↓
  2. 2024
    Annual accounts 202452,8 k €↑
  3. 2023
    Annual accounts 202316,3 k €↓
  4. 2022
    Annual accounts 202219,8 k €↓
  5. 2022
    Name changeDOKTERS BUYSE-KENIS
  6. 2021
    Annual accounts 202145,1 k €↑
  7. 2021
    Name changeBuyse - Kenis Dokters
  8. 2020
    Annual accounts 202040,3 k €↑
  9. 2019
    Annual accounts 201932,1 k €↑
  10. 2018
    Annual accounts 2018-7,6 k €↓
  11. 2017
    Annual accounts 201734 k €↑
  12. 2016
    Annual accounts 2016799,3 €↓
  13. 2015
    Annual accounts 201520,5 k €↓
  14. 2014
    Annual accounts 201424,9 k €↑
  15. 2013
    Annual accounts 201324,5 k €↑
  16. 2012
    Annual accounts 2012-3,6 k €
  17. 21/03/1994
    IncorporationPrivate limited company